Andrea Edginton
Andrea Edginton (BSc and PhD, University of Guelph) has been named the next Hallman Director of the School of Pharmacy.  Professor Edginton is a globally recognized leader in physiologically-based pharmacokinetic (PBPK) modeling and simulation, specializing in dose-exposure extrapolation to special populations.  She was a founding member of the School of Pharmacy and currently serves as the School’s Associate Director, Graduate Studies and Research (2018) and member of the Executive leadership team (2015).

Following her education, Edginton did a post-doctoral fellowship at Bayer Technology Services (BTS) in Germany, followed by a position as PBPK scientist within BTS’s Systems Biology Group. She joined the Waterloo School of Pharmacy in 2008, a time of curricular development, infrastructure expansion and hiring. Two years into her position, she was appointed Graduate Officer (2010-2012) where she led the fledgling MSc (2010) program and developed the PhD (2014) program.  In 2013/14, she chaired the Self-Study for accreditation of the BPharm/PharmD program which resulted in six years of accreditation.  As Programmatic Assessment Officer and chair of the School’s Assessment Committee (2015-2017), Edginton introduced a 2nd year MidPoint Assessment Exam that earned her and the committee the AFPC/Pharmacy Examining Board of Canada (PEBC) Award for Excellence in Research or Innovation in Assessment of Competence. Support of teaching and learning in the PharmD and graduate-level programs has been, and will continue to be, a focus in the Hallman Director role.

Edginton has a strong, collaborative research program and has worked hard to cultivate a barrier-free research culture within the School. Innovation and knowledge translation are central to her vision for the School and her own entrepreneurial endeavors bring a seasoned awareness of their importance. At the University level, Edginton chaired the Clinical Research Ethics Committee (2013-2019), aiming to facilitate human participant research by bringing in policies for coordinated ethics review with partner institutions, evaluation of devices used in human research and contributing to the accreditation process for Waterloo becoming a board of record for Clinical Trials Ontario.

Throughout her career at the University of Waterloo, Edginton has been active with the Association of Faculties of Pharmacy and the Canadian Council for Accreditation of Pharmacy Programs (CCAPP) and looks forward to bringing her unique perspective to working with professional and regulatory organizations including the Ontario College of Pharmacists, Ontario Pharmacists Association, Canadian Pharmacists Association and Canadian Society of Hospital Pharmacists.

Edginton is excited by the prospect of leading the School’s outstanding Pharmacy team, saying:

"Over the last 12 years, I have witnessed exceptional faculty and staff who have been dedicated to providing students and trainees with an education that sets them apart. We have built the most innovative pharmacy school in Canada while maintaining a collaborative, supportive environment. I am thrilled to lead this outstanding team as we build on this culture of excellence."

- Andrea Edginton

Professor Edginton will be Waterloo Pharmacy's third Hallman Director. She succeeds David Edwards, who has held the position since 2011. Her four-year appointment begins on January 1, 2021.